Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.

Benedetta StefaniniLaura BucciValentina SantiNicola ReggidoriLorenzo LaniAlessandro GranitoFilippo PelizzaroGiuseppe CabibboMariella Di MarcoGiorgia GhittoniClaudia CampaniGianluca Svegliati-BaroniFrancesco Giuseppe FoschiEdoardo G GianniniElisabetta BiasiniCarlo SaittaDonatella MagalottiAngelo SangiovanniMaria GuarinoAntonio GasbarriniGian Ludovico RapacciniAlberto MasottoRodolfo SaccoGianpaolo VidiliAndrea MegaFrancesco AzzaroliGerardo NardoneGiovanni BrandiSimone SabbioniAlessandro VitaleFranco Trevisani

Published in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2024)

C-P B patients with aHCC undergoing BSC have poor survival. Both Sorafenib and MC treatment improve their prognosis.

Keyphrases

healthcare
palliative care
mental health
clinical trial
phase ii study
metastatic breast cancer
metastatic colorectal cancer
open label
double blind